News
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,030.00. The company’s shares closed yesterday at $686.33 ...
Regeneron Pharmaceuticals Inc. closed 55.21% below its 52-week high of $1,211.20, which the company reached on August 27th.
Jefferies analyst Akash Tewari maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,200.00. The company’s shares opened today at $710.20. Discover ...
Regeneron Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest REGN financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results